Skip to main content

Advertisement

Log in

Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

To protect the small intestine from mucosal injury induced by nonsteroidal anti-inflammatory drugs is one of the critical issues in the field of gastroenterology. Polaprezinc (PZ), a gastric muco-protecting agent, has been widely used for the treatment of gastric ulcer and gastritis for its unique effects, such as its strong reactive oxygen species (ROS)-quenching effect. The aim of this study was to clarify the mechanism by which indomethacin-induced small intestinal mucosal injury occurs, by using a rat intestinal epithelial cell line (RIE-1). In addition, the protective role of PZ and the possible mechanism of its effect on indomethacin-induced small intestinal injury were investigated.

Methods

Cell death was evaluated by methyl thiazolyl tetrazolium (MTT) assay and a double-staining method with Hoechst33342 dye and propidium iodide. Indomethacin-induced ROS production was evaluated by detecting the oxidation of a redox-sensitive fluorogenic probe, RedoxSensor, and the oxidation of cysteine residues of proteins (protein S oxidation). The activation of cytochrome c, smac/DIABLO, and caspase-3 was assessed by western blotting. In some experiments, PZ or its components, l-carnosine and zinc, were used.

Results

We found that indomethacin caused apoptosis in RIE-1 cells in a dose- and time-dependent manner. Indomethacin also induced ROS production and an increase in the protein S oxidation of RIE-1. Pretreatment of RIE-1 with PZ or zinc sulfate, but not l-carnosine, significantly reduced the indomethacin-induced apoptosis. PZ prevented ROS production and the increase in protein S-oxidation. PZ inhibited indomethacin-induced cytochrome c and smac/DIABLO release and subsequent caspase-3 activation.

Conclusions

The protective effect of PZ on indomethacin-induced small intestinal injury may be dependent on its ROS-quenching effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5:1040–5.

    Article  PubMed  Google Scholar 

  2. Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol. 2008;43:490–6.

    Article  CAS  PubMed  Google Scholar 

  3. Adebayo D, Bjarnason I. Is non-steroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J. 2006;82:186–91.

    Article  CAS  PubMed  Google Scholar 

  4. Peura DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med. 2004;117(Suppl 5A):63S–71S.

    CAS  PubMed  Google Scholar 

  5. Schoenfeld P, Kimmey MB, Scheiman J, Bjorkman D, Laine L. Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications–guidelines for prevention and treatment. Aliment Pharmacol Ther. 1999;13:1273–85.

    Article  CAS  PubMed  Google Scholar 

  6. Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med. 2006;17:89–93.

    CAS  PubMed  Google Scholar 

  7. Bjarnason I, Smethurst P, Fenn CG, Lee CE, Menzies IS, Levi AJ. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989;34:407–11.

    Article  CAS  PubMed  Google Scholar 

  8. Davies GR, Wilkie ME, Rampton DS. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci. 1993;38:417–25.

    Article  CAS  PubMed  Google Scholar 

  9. Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992;33:1204–8.

    Article  CAS  PubMed  Google Scholar 

  10. Omatsu T, Naito Y, Handa O, Hayashi N, Mizushima K, Qin Y. et al. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells. J Gastroenterol. 2009;44(Suppl 19):30–4.

    Article  CAS  PubMed  Google Scholar 

  11. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Yasuda M, Ueda S, et al. Effect of zinc-carnosine chelate compound (Z-103), a novel antioxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Free Radic Res Commun. 1991;14:289–96.

    Article  CAS  PubMed  Google Scholar 

  12. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M. The antioxidant properties of a novel zinc–carnosine chelate compound, N-(3-aminopropionyl)-l-histidinato zinc. Biochim Biophys Acta. 1991;1115:15–22.

    CAS  PubMed  Google Scholar 

  13. Ito M, Tanaka T, Suzuki Y. Effect of N-(3-aminopropionyl)-l-histidinato zinc (Z-103) on healing and hydrocortisone-induced relapse of acetic acid ulcers in rats with limited food-intake-time. Jpn J Pharmacol. 1990;52:513–21.

    Article  CAS  PubMed  Google Scholar 

  14. Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion. 1997;58:464–8.

    Article  CAS  PubMed  Google Scholar 

  15. Fujii Y, Matsura T, Kai M, Kawasaki H, Yamada K. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells. Jpn J Pharmacol. 2000;84:63–70.

    Article  CAS  Google Scholar 

  16. Blay J, Brown KD. Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biol Int Rep. 1984;8:551–60.

    Article  CAS  PubMed  Google Scholar 

  17. Handa O, Kokura S, Adachi S, Takagi T, Naito Y, Tanigawa T, et al. Methylparaben potentiates UV-induced damage of skin keratinocytes. Toxicology. 2006;227:62–72.

    Article  CAS  PubMed  Google Scholar 

  18. Manabe E, Handa O, Naito Y, Mizushima K, Akagiri S, Adachi S, et al. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J Cell Biochem. 2008;103:1925–37.

    Article  CAS  PubMed  Google Scholar 

  19. Naito Y, Handa O, Takagi T, Ishikawa T, Imamoto E, Nakagawa S, et al. Ubiquitin-proteasome inhibitor enhances tumour necrosis factor-alpha-induced apoptosis in rat gastric epithelial cells. Aliment Pharmacol Ther. 2002;16(Suppl 2):59–66.

    Article  CAS  PubMed  Google Scholar 

  20. Omatsu T, Naito Y, Handa O, Hayashi N, Hirata I, Okayama T, et al. Anti-apoptotic effect of vitamin E on indomethacin-induced intestinal epithelial cell injury. J Clin Biochem Nutr. 2008;43(Suppl 1):433–5.

    Google Scholar 

  21. Hvidberg E, Lausen HH, Jansen JA. Indomethacin: plasma concentrations and protein binding in man. Eur J Clin Pharmacol. 1972;4:119–24.

    Article  CAS  PubMed  Google Scholar 

  22. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232–5.

    CAS  PubMed  Google Scholar 

  23. Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–85.

    Article  CAS  PubMed  Google Scholar 

  24. Ogunwobi OO, Beales IL. Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells. Dig Dis Sci. 2007;52:1934–45.

    Article  CAS  PubMed  Google Scholar 

  25. Babbar N, Ignatenko NA, Casero RA Jr, Gerner EW. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem. 2003;278:47762–75.

    Article  CAS  PubMed  Google Scholar 

  26. Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst. 2006;98:736–47.

    Article  PubMed  CAS  Google Scholar 

  27. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832–47.

    CAS  PubMed  Google Scholar 

  28. Nagano Y, Matsui H, Muramatsu M, Shimokawa O, Shibahara T, Yanaka A, et al. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci. 2005;50(Suppl 1):S76–83.

    Article  CAS  PubMed  Google Scholar 

  29. Suzuki H, Hibi T. Oxidative stress in digestive diseases: oxidative stress in Helicobacter pylori associated gastroduodenal disease. J Clin Biochem Nutr. 2006;39:56–63.

    Article  CAS  Google Scholar 

  30. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.

    Article  PubMed  Google Scholar 

  31. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990;259:G462–7.

    CAS  PubMed  Google Scholar 

  32. Naito Y, Yoshikawa T, Yoshida N, Kondo M. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci. 1998;43:30S–4S.

    CAS  PubMed  Google Scholar 

  33. Handa O, Naito Y, Takagi T, Shimozawa M, Kokura S, Yoshida N, et al. Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-kappaB. J Pharmacol Exp Ther. 2004;309:670–6.

    Article  CAS  PubMed  Google Scholar 

  34. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007;73:1697–702.

    Article  CAS  PubMed  Google Scholar 

  35. Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield AJ. Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut. 1996;39:363–8.

    Article  CAS  PubMed  Google Scholar 

  36. Chattopadhyay I, Bandyopadhyay U, Biswas K, Maity P, Banerjee RK. Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic Biol Med. 2006;40:1397–408.

    Article  CAS  PubMed  Google Scholar 

  37. Stowe DF, Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal. 2009;11:1373–414.

    Article  CAS  PubMed  Google Scholar 

  38. Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, et al. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J Biol Chem. 2009;284:3058–68.

    Article  CAS  PubMed  Google Scholar 

  39. Ohkawara T, Nishihira J, Nagashima R, Takeda H, Asaka M. Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins. World J Gastroenterol. 2006;12:6178–81.

    CAS  PubMed  Google Scholar 

  40. Ueda K, Ueyama T, Oka M, Ito T, Tsuruo Y, Ichinose M. Polaprezinc (zinc l-carnosine) is a potent inducer of anti-oxidative stress enzyme, heme oxygenase (HO)-1—a new mechanism of gastric mucosal protection. J Pharmacol Sci. 2009;110:285–94.

    Article  CAS  PubMed  Google Scholar 

  41. Handa O, Yoshida N, Tanaka Y, Ueda M, Ishikawa T, Takagi T, et al. Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori. Can J Gastroenterol. 2002;16:785–9.

    PubMed  Google Scholar 

  42. Szuster-Ciesielska A, Plewka K, Daniluk J, Kandefer-Szerszen M. Zinc inhibits ethanol-induced HepG2 cell apoptosis. Toxicol Appl Pharmacol. 2008;229:1–9.

    Article  CAS  PubMed  Google Scholar 

  43. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001;14:315–30.

    Article  CAS  PubMed  Google Scholar 

  44. Nagai K, Suda T, Kawasaki K, Mathuura S. Action of carnosine and beta-alanine on wound healing. Surgery. 1986;100:815–21.

    CAS  PubMed  Google Scholar 

  45. Fouad AA, El-Rehany MA, Maghraby HK. The hepatoprotective effect of carnosine against ischemia/reperfusion liver injury in rats. Eur J Pharmacol. 2007;572:61–8.

    Article  CAS  PubMed  Google Scholar 

  46. Suzuki H, Mori M, Seto K, Nagahashi S, Kawaguchi C, Morita H, et al. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation. J Gastroenterol. 1999;34(Suppl 11):43–6.

    CAS  PubMed  Google Scholar 

  47. Green D, Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 1998;8:267–71.

    Article  CAS  PubMed  Google Scholar 

  48. Gulbins E, Dreschers S, Bock J. Role of mitochondria in apoptosis. Exp Physiol. 2003;88:85–90.

    Article  CAS  PubMed  Google Scholar 

  49. Verhagen AM, Coulson EJ, Vaux DL. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001;2:REVIEWS3009.1–3009.10.

    Google Scholar 

  50. Kohli M, Yu J, Seaman C, Bardelli A, Kinzler KW, Vogelstein B, et al. SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells. Proc Natl Acad Sci USA. 2004;101:16897–902.

    Article  CAS  PubMed  Google Scholar 

  51. Ganju N, Eastman A. Zinc inhibits Bax and Bak activation and cytochrome c release induced by chemical inducers of apoptosis but not by death-receptor-initiated pathways. Cell Death Differ. 2003;10:652–61.

    Article  CAS  PubMed  Google Scholar 

  52. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, et al. Polaprezinc (N-(3-aminopropionyl)-l-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol. 2005;40:1321–7.

    Article  CAS  PubMed  Google Scholar 

  53. Suzuki H, Mori M, Seto K, Miyazawa M, Kai A, Suematsu M, et al. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils–a study using intravital videomicroscopy. Aliment Pharmacol Ther. 2001;15:715–25.

    Article  CAS  PubMed  Google Scholar 

  54. Matsuu-Matsuyama M, Shichijo K, Okaichi K, Nakayama T, Nakashima M, Uemura T, et al. Protection by polaprezinc against radiation-induced apoptosis in rat jejunal crypt cells. J Radiat Res (Tokyo). 2008;49:341–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuji Naito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omatsu, T., Naito, Y., Handa, O. et al. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury. J Gastroenterol 45, 692–702 (2010). https://doi.org/10.1007/s00535-010-0213-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0213-9

Keywords

Navigation